EYPT EyePoint, Inc. - Common Stock
$5,96
Fiyat · Ağu 19, 2026
Temel veriler itibarıyla Ağu 5, 2026
52 Haftlık Aralık
$4–$19
13% of range
Analist Derecelendirmesi
BUY
20 analysts
Fiyat Hedefi
$37
+514% upside
P/E (TTM)
-1.9
ROE
-84.0%
Net Kâr Marjı
-739.4%
EyePoint, Inc. - Common Stock Hakkında Wikipedia'dan şirket genel bakışı
EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems (MEMS) and nanotechnology to drug delivery.
Devamını oku
EyePoint Pharmaceuticals Inc. (formerly pSivida Corporation) is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems (MEMS) and nanotechnology to drug delivery.
pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency (DERA, now QinetiQ). QinetiQ continues to be a strategic partner.
In June 2004, pSivida acquired full ownership of pSiMedica. In April 2018, pSivida purchased eye products firm Icon Bioscience. Afterwards, it rebranded to its current name of EyepOint Pharmaceuticals, Inc.
Kaynak: Wikipedia (İngilizce), CC BY-SA 4.0 · Wikipedia'da Görüntüle ↗
EYPT Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$5.96
Piyasa Değeri
$494M
P/E (TTM)
-1.9
EPS (TTM)
$-3.17
Gelir (TTM)
$31M
Temettü Verimi
—
ROE
-84.0%
D/E Borç/Özsermaye
—
52 Haftlık Aralık
$4 – $19
EYPT Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
$31M
2017-06-30
→
2025-12-31
Hisse Başına Kâr
$-3.17
2017-06-30
→
2025-12-31
Serbest Nakit Akışı
$-243M
2019-12-31
→
2025-12-31
Marjlar
-739.4%
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
EYPT
Akran Ortalaması
P/E (TTM)
-1.9
29.9
P/S (TTM) (F/S (TTM))
15.7
14.4
P/B (F/D)
1.6
4.4
Price / FCF (Fiyat / Serbest Nakit Akışı)
-2.0
—
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
EYPT
Akran Ortalaması
Operating Margin (Faaliyet Kâr Marjı)
-776.0%
—
Net Profit Margin (Net Kâr Marjı)
-739.4%
0.70%
ROA
-59.3%
-0.55%
ROE
-84.0%
-2.5%
ROIC
-79.6%
—
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
EYPT
Akran Ortalaması
Current Ratio (Cari Oran)
8.9
3.9
Quick Ratio (Cari Oran)
8.3
—
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
EYPT
Akran Ortalaması
Revenue YoY (Gelir Yıllık Bazda)
-27.5%
—
Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı)
-8.8%
—
Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı)
-1.8%
—
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
EYPT
Akran Ortalaması
EYPT Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
AL
20 analist
- Güçlü Al 7 35,0%
- Al 12 60,0%
- Tut 1 5,0%
- Sat 0 0,0%
- Güçlü Sat 0 0,0%
12 Aylık Fiyat Hedefi
13 analist · 2026-08-19
Medyan
$37.00
← Tüm hedeflerin altında
$5.96
Düşük
$8.00
Yüksek
$68.00
Medyan hedef
$37.00
+520,8%
Ortalama hedef
$36.62
+514,4%
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-0.07%
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 30 Haziran 2026 | $-1.09 | $-0.97 | -0.12% |
| 31 Mart 2026 | $-0.99 | $-0.82 | -0.17% |
| 31 Aralık 2025 | $-0.81 | $-0.76 | -0.05% |
| 30 Eylül 2025 | $-0.85 | $-0.80 | -0.05% |
| 30 Haziran 2025 | $-0.85 | $-0.81 | -0.04% |
| 31 Mart 2025 | $-0.65 | $-0.67 | 0.02% |
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| EYPT | $1.51B | -5.8 | -27.5% | -739.4% | -84.0% | — |
| AQST | $788M | -8.3 | -22.6% | -188.1% | 157.7% | — |
| CTNM | — | -5.3 | — | — | -27.7% | — |
| ZVRA | $509M | 6.6 | 350.9% | 78.2% | 61.2% | — |
| EOLS | $432M | -8.3 | 11.6% | -17.4% | 247.3% | 66.3% |
| RLMD | $354M | -3.3 | 93.7% | — | -112.0% | — |
| BIOA | $495M | -5.9 | — | -896.1% | -28.4% | — |
| AVIR | $279M | -1.8 | — | — | -49.5% | — |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 16
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $31M | $43M | $46M | $41M | $37M | $34M | $20M | $5M | $8M | $2M | $27M | |
| R&D Expense | $221M | $133M | $65M | $50M | $28M | $17M | $15M | $19M | $15M | $14M | $12M | |
| SG&A Expense | $52M | $52M | $40M | $35M | $26M | $21M | $18M | $15M | $11M | $9M | $8M | |
| Operating Expenses | $275M | $189M | $121M | $141M | $92M | $72M | $68M | $44M | $26M | $23M | $20M | |
| Operating Income | $-243M | $-146M | $-75M | $-100M | $-55M | $-37M | $-48M | $-39M | $-19M | $-22M | $6M | |
| Interest Expense | · | · | $1M | $3M | $5M | $7M | $6M | $2M | $0 | $0 | · | |
| Interest Income | · | · | · | · | · | · | · | · | · | · | $19.0K | |
| Other Non-op | $12M | $15M | $7M | $2M | $292.0K | $58.0K | $1M | $420.0K | $91.0K | $72.0K | $22.0K | |
| Pretax Income | $-232M | $-131M | $-71M | $-102M | $-58M | $-45M | $-57M | · | $-18M | $-22M | $6M | |
| Income Tax | $279.0K | $90.0K | $83.0K | · | $0 | $0 | $0 | · | $0 | $-155.0K | $96.0K | |
| Net Income | $-232M | $-131M | $-71M | $-102M | $-58M | $-45M | $-57M | $-86M | $-18M | $-22M | $6M | |
| EPS (Basic) | $-3.17 | $-2.32 | $-1.82 | $-2.74 | $-2.03 | · | · | · | $-0.52 | $-0.68 | $0.22 | |
| EPS (Diluted) | $-3.17 | $-2.32 | $-1.82 | $-2.74 | $-2.03 | · | · | · | $-0.52 | $-0.68 | $0.21 | |
| Shares (Basic) | 73,251 | 56,298 | 38,904 | 37,317,000 | 28,758,000 | · | · | · | 35,343,765 | 31,623,473 | 29,378,250 | |
| Shares (Diluted) | 73,251 | 56,298 | 38,904 | 37,317,000 | 28,758,000 | · | · | · | 35,343,765 | 31,623,473 | 30,584,140 | |
| EBITDA | $-241M | $-146M | $-75M | $-100M | $-55M | · | $-48M | · | · | $-22M | $6M |
Bilanço 27
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $102M | $100M | $281M | $96M | $179M | $45M | $22M | $45M | $17M | $15M | $19M | |
| Short-term Investments | $204M | $271M | $50M | $49M | $33M | $0 | $0 | $0 | $0 | $14M | $9M | |
| Inventory | $2M | $2M | $4M | $3M | $4M | $5M | $2M | $279.0K | · | · | · | |
| Prepaid Expense | $20M | $9M | $9M | $10M | $4M | $3M | $6M | $1M | $591.0K | $483.0K | $681.0K | |
| Other Current Assets | $2M | $1M | $1M | $782.0K | $517.0K | · | · | · | · | · | · | |
| Current Assets | $329M | $383M | $345M | $173M | $238M | $63M | $42M | $48M | $18M | $30M | $30M | |
| PP&E (Net) | $9M | $8M | $5M | $1M | $476.0K | $630.0K | $357.0K | $288.0K | $313.0K | $290.0K | $338.0K | |
| PP&E (Gross) | $15M | $12M | $8M | $3M | $2M | $2M | $1M | $983.0K | $799.0K | $2M | $2M | |
| Accum. Depreciation | $6M | $4M | $3M | $2M | $1M | $1M | $839.0K | $695.0K | $486.0K | $2M | $2M | |
| Intangibles | · | · | · | $0 | $23M | $25M | $28M | $30M | $364.0K | $1M | $2M | |
| Other Non-current Assets | $6M | $6M | $0 | · | · | · | · | · | · | · | · | |
| Total Assets | $364M | $418M | $355M | $180M | $263M | $92M | $73M | $78M | $19M | $32M | $32M | |
| Accounts Payable | $10M | $12M | $7M | $6M | $7M | $5M | $4M | $3M | $1M | $1M | $744.0K | |
| Accrued Liabilities | $24M | $18M | $18M | $16M | $14M | $8M | $7M | $4M | $4M | $4M | $3M | |
| Short-term Debt | · | · | $0 | $10M | $0 | · | · | · | · | · | · | |
| Current Liabilities | $37M | $49M | $63M | $35M | $24M | $15M | $12M | $21M | $5M | $5M | $3M | |
| Capital Leases | $21M | $22M | $5M | $6M | $2M | $2M | $3M | $0 | · | · | · | |
| Other Non-current Liabilities | $87.0K | $205.0K | $0 | $600.0K | $2M | $2M | $3M | $1M | $51.0K | · | · | |
| Total Liabilities | $58M | $82M | $89M | $84M | $79M | $73M | $65M | $41M | $5M | $11M | $9M | |
| Long-term Debt | · | · | · | $30M | · | · | · | · | · | · | · | |
| Total Debt | · | · | $0 | $40M | $37M | · | $47M | · | · | · | · | |
| Common Stock | $83.0K | $68.0K | $49.0K | $34.0K | $34.0K | $18.0K | $11.0K | $95.0K | $39.0K | $34.0K | $29.0K | |
| Retained Earnings | $-1.10B | $-873M | $-742M | $-671M | $-569M | $-511M | $-465M | $-408M | $-311M | $-292M | $-271M | |
| AOCI | $961.0K | $1M | $864.0K | $786.0K | $841.0K | $841.0K | $840.0K | $839.0K | $833.0K | $852.0K | $945.0K | |
| Stockholders' Equity | $306M | $337M | $266M | $96M | $184M | $19M | $8M | $38M | $13M | $21M | $23M | |
| Liabilities + Equity | $364M | $418M | $355M | $180M | $263M | $92M | $73M | $78M | $19M | $32M | $32M | |
| Shares Outstanding | 82,826,416 | 68,266,005 | 49,043,074 | 34,082,934 | 33,905,826 | 18,139,981 | 10,941,659 | 95,372,236 | 39,356,999 | 34,172,919 | 29,412,365 |
Nakit Akışı 18
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $464.0K | · | · | · | · | · | · | · | · | |
| Stock-based Comp | $28M | $37M | $12M | $14M | $7M | $6M | $5M | · | $2M | $2M | $2M | |
| Deferred Tax | $279.0K | $90.0K | $83.0K | · | · | · | · | · | · | · | · | |
| Amort. of Intangibles | · | · | $0 | $2M | $2M | $2M | $2M | $981.0K | $724.0K | $756.0K | $770.0K | |
| Restructuring | · | · | · | · | · | $590.0K | · | · | $472.0K | · | · | |
| Other Non-cash | $-39M | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-240M | $-126M | $2M | $-65M | $-50M | $-14M | $-57M | · | $-20M | $-16M | $10M | |
| CapEx | $3M | $4M | $3M | $2M | $156.0K | $362.0K | $213.0K | · | $147.0K | $113.0K | $161.0K | |
| Investing Cash Flow | $69M | $-219M | $-3M | $-17M | $-33M | $-362.0K | $-213.0K | · | $14M | $-4M | · | |
| Debt Issued | · | · | $0 | $30M | $0 | · | $50M | · | $0 | $0 | · | |
| Net Debt Issued | · | $0 | $-30M | $-8M | $0 | · | $30M | · | · | · | · | |
| Stock Issued | $173M | $163M | $226M | $0 | · | $50M | $23M | · | $8M | $16M | $0 | |
| Net Stock Activity | $173M | $163M | $226M | · | · | · | $23M | · | · | $16M | · | |
| Financing Cash Flow | $174M | $164M | $187M | $-690.0K | $217M | $37M | $34M | · | $9M | $17M | · | |
| Net Change in Cash | $2M | $-182M | $186M | $-83M | $134M | $23M | $-23M | · | $2M | $-4M | $4M | |
| Taxes Paid | $200.0K | $100.0K | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-243M | $-130M | $-2M | $-67M | $-50M | · | $-57M | · | · | $-16M | $10M | |
| Levered FCF | · | · | $-3M | $-70M | $-56M | · | $-63M | · | · | · | · |
Kârlılık 7
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -776.0% | -337.1% | -163.1% | -240.6% | -149.6% | · | -235.0% | · | · | -1344.1% | 24.2% | |
| Net Margin | -739.4% | -302.4% | -153.8% | -247.0% | -158.1% | · | -278.9% | · | · | -1330.1% | 23.9% | |
| Pretax Margin | -738.5% | -302.2% | -153.7% | -247.0% | -158.1% | · | -278.9% | · | · | -1339.6% | 24.2% | |
| EBITDA Margin | -768.6% | -337.1% | -163.1% | -240.6% | -149.6% | · | -235.0% | · | · | -1344.1% | 24.2% | |
| ROA | -59.3% | -33.8% | -26.4% | -46.1% | -32.9% | · | -75.1% | · | · | -67.3% | 23.1% | |
| ROE | -84.0% | -47.1% | -43.6% | -87.9% | -42.2% | · | -468.1% | · | · | -90.8% | 24.8% | |
| ROIC | -79.6% | -43.4% | -28.2% | -73.2% | -25.0% | · | -86.2% | · | · | -103.5% | 27.1% |
Likidite ve Solventlik 5
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.9 | 7.8 | 5.5 | 5.0 | 10.0 | · | 3.6 | · | · | 5.9 | 8.9 | |
| Quick Ratio | 8.3 | 7.6 | 5.2 | 4.2 | 8.9 | · | 1.9 | · | · | 5.7 | 8.5 | |
| Debt / Equity | · | · | 0.0 | 0.4 | 0.2 | · | 5.7 | · | · | · | · | |
| LT Debt / Equity | · | · | · | 0.3 | 0.2 | · | 5.7 | · | · | · | · | |
| Interest Coverage | · | · | -60.2 | -31.2 | -10.1 | · | -7.7 | · | · | · | · |
Verimlilik 1
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | · | 0.3 | · | · | 0.1 | 1.0 |
Büyüme Oranları 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -27.5% | -6.0% | 11.1% | 12.1% | 7.3% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -8.8% | 5.4% | 10.2% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -1.8% | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM) 14
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $31M | $43M | $46M | $41M | $37M | $34M | $20M | · | $8M | $2M | $27M | |
| Net Income TTM | $-232M | $-131M | $-71M | $-102M | $-58M | $-45M | $-57M | · | $-18M | $-22M | $6M | |
| Market Cap | $1.51B | $509M | $1.13B | $119M | $415M | · | $1.70B | · | · | $967M | $1.11B | |
| Enterprise Value | · | · | $802M | $15M | $240M | · | $1.72B | · | · | · | · | |
| P/E | -5.8 | -3.2 | -12.7 | -1.3 | -6.0 | -9.8 | -23.1 | · | -32.9 | -41.6 | 179.5 | |
| P/S | 48.2 | 11.8 | 24.6 | 2.9 | 11.2 | · | 83.3 | · | · | 597.0 | 41.7 | |
| P/B | 4.9 | 1.5 | 4.3 | 1.2 | 2.3 | · | 203.6 | · | · | 46.3 | 47.5 | |
| P / Tangible Book | 4.9 | 1.5 | 4.3 | 1.2 | 2.6 | · | · | · | · | · | · | |
| P / Cash Flow | -6.3 | -4.0 | 604.5 | -1.8 | -8.3 | · | -29.9 | · | · | -59.3 | 107.7 | |
| P / FCF | -6.2 | -3.9 | -704.8 | -1.8 | -8.3 | · | -29.8 | · | · | -58.9 | 109.4 | |
| EV / EBITDA | · | · | -10.7 | -0.1 | -4.3 | · | -36.0 | · | · | · | · | |
| EV / FCF | · | · | -499.0 | -0.2 | -4.8 | · | -30.2 | · | · | · | · | |
| EV / Revenue | · | · | 17.4 | 0.4 | 6.5 | · | 84.5 | · | · | · | · | |
| Earnings Yield | -17.3% | -31.1% | -7.9% | -78.3% | -16.6% | -10.2% | -4.3% | · | -3.0% | -2.4% | 0.56% |
Gelir Tablosu 16
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $507.0K | $696.0K | $619.0K | $966.0K | $5M | $24M | $12M | $11M | $9M | $12M | $14M | $15M | $9M | $8M | $11M | $10M | |
| Cost of Revenue | · | · | · | · | · | · | · | $736.0K | $1M | $759.0K | · | $1M | $2M | $640.0K | · | · | |
| R&D Expense | $84M | $72M | $59M | $48M | $55M | $59M | $43M | $30M | $30M | $30M | $18M | $17M | $16M | $14M | $16M | $11M | |
| SG&A Expense | $14M | $15M | $11M | $14M | $12M | $14M | $13M | $13M | $13M | $14M | $11M | $11M | $9M | $9M | $8M | $9M | |
| Operating Expenses | $98M | $88M | $71M | $63M | $68M | $73M | $57M | $43M | $44M | $45M | $30M | $30M | $32M | $29M | $54M | $28M | |
| Operating Income | $-97M | $-87M | $-70M | $-62M | $-62M | $-49M | $-45M | $-33M | $-35M | $-33M | $-16M | $-14M | $-23M | $-22M | $-44M | $-18M | |
| Interest Expense | · | · | · | · | · | · | · | · | $0 | $0 | · | $0 | $435.0K | $812.0K | $781.0K | $662.0K | |
| Other Non-op | $3M | $2M | $3M | $2M | $3M | $4M | $4M | $3M | $4M | $4M | $2M | $2M | $2M | $1M | $1M | $640.0K | |
| Pretax Income | $-94M | · | $-67M | $-60M | $-59M | · | $-41M | $-29M | $-31M | · | · | · | · | · | · | · | |
| Income Tax | $0 | $-50.0K | $186.0K | $0 | $93.0K | $0 | $90.0K | $0 | $0 | · | · | · | · | · | · | · | |
| Net Income | $-94M | $-85M | $-68M | $-60M | $-59M | $-45M | $-41M | $-29M | $-31M | $-29M | $-14M | $-13M | $-23M | $-21M | $-43M | $-18M | |
| EPS (Basic) | $-1.09 | $-0.99 | $-0.82 | $-0.85 | $-0.85 | $-0.65 | $-0.65 | $-0.54 | $-0.58 | $-0.55 | $-0.32 | $-0.33 | $-0.61 | $-0.56 | $-1.17 | $-0.49 | |
| EPS (Diluted) | $-1.09 | $-0.99 | $-0.82 | $-0.85 | $-0.85 | $-0.65 | $-0.65 | $-0.54 | $-0.58 | $-0.55 | $-0.32 | $-0.33 | $-0.61 | $-0.56 | $-1.17 | $-0.49 | |
| Shares (Basic) | 86,543 | 85,999 | -69,833,843 | 70,168 | 69,926 | 69,767 | -52,964,357 | 54,449 | 53,206 | 52,913,000 | -75,915,582 | 38,341,000 | 37,576,000 | 37,486 | -74,596,000 | 37,338,000 | |
| Shares (Diluted) | 86,543 | 85,999 | -69,833,843 | 70,168 | 69,926 | 69,767 | -52,964,357 | 54,449 | 53,206 | 52,913,000 | -75,915,582 | 38,341,000 | 37,576,000 | 37,486 | -74,596,000 | 37,338,000 | |
| EBITDA | $-97M | $-87M | · | $-62M | $-62M | $-49M | · | $-33M | $-35M | $-33M | · | $-14M | $-23M | $-22M | · | $-18M |
Bilanço 27
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $110M | $78M | $102M | $75M | $71M | $85M | $100M | $80M | $91M | $271M | $281M | $133M | $140M | $106M | $96M | $75M | |
| Short-term Investments | $70M | $145M | $204M | $129M | $185M | $233M | $271M | $174M | $189M | $28M | $50M | $3M | $3M | $17M | $49M | $82M | |
| Inventory | $2M | $1M | $2M | $2M | $3M | $2M | $2M | $3M | $4M | $4M | $4M | $5M | $4M | $4M | $3M | $4M | |
| Prepaid Expense | $6M | $25M | $20M | $9M | $6M | $6M | $9M | $12M | $10M | $11M | $9M | $9M | $9M | $9M | $10M | $10M | |
| Other Current Assets | $987.0K | $1M | $2M | $899.0K | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $549.0K | $0 | $0 | $782.0K | · | |
| Current Assets | $189M | $250M | $329M | $216M | $265M | $327M | $383M | $269M | $295M | $318M | $345M | $150M | $167M | $146M | $173M | $192M | |
| PP&E (Net) | $10M | $9M | $9M | $9M | $9M | $8M | $8M | $8M | $7M | $7M | $5M | $4M | $3M | $3M | $1M | $1M | |
| PP&E (Gross) | · | · | $15M | · | · | · | $12M | · | · | · | $8M | · | · | · | $3M | · | |
| Accum. Depreciation | · | · | $6M | · | · | · | $4M | · | · | · | $3M | · | · | · | $2M | · | |
| Intangibles | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $21M | |
| Other Non-current Assets | $9M | $9M | $6M | $6M | $6M | $6M | $6M | $2M | · | · | $0 | · | · | · | · | · | |
| Total Assets | $228M | $288M | $364M | $252M | $301M | $363M | $418M | $301M | $324M | $329M | $355M | $160M | $176M | $155M | $180M | $220M | |
| Accounts Payable | $17M | $19M | $10M | $10M | $20M | $16M | $12M | $7M | $14M | $7M | $7M | $10M | $11M | $9M | $6M | $6M | |
| Accrued Liabilities | $22M | $16M | $24M | $18M | $11M | $18M | $18M | $14M | $13M | $16M | $18M | $13M | $15M | $10M | $16M | $16M | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $5M | $10M | $10M | |
| Current Liabilities | $42M | $37M | $37M | $30M | $33M | $42M | $49M | $49M | $62M | $63M | $63M | $64M | $69M | $27M | $35M | $34M | |
| Capital Leases | $20M | $20M | $21M | $21M | $22M | $22M | $22M | $22M | $22M | $5M | $5M | $5M | $5M | $6M | $6M | $6M | |
| Other Non-current Liabilities | $23.0K | $55.0K | $87.0K | $118.0K | $148.0K | $177.0K | $205.0K | $233.0K | · | · | $0 | $0 | $0 | $600.0K | $600.0K | $600.0K | |
| Total Liabilities | $62M | $58M | $58M | $52M | $55M | $64M | $82M | $82M | $96M | $79M | $89M | $101M | $118M | $76M | $84M | $84M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | $30M | · | $30M | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $35M | · | $40M | |
| Common Stock | $85.0K | $83.0K | $83.0K | $70.0K | $69.0K | $69.0K | $68.0K | $53.0K | $52.0K | $50.0K | $49.0K | $35.0K | $34.0K | $34.0K | $34.0K | $34.0K | |
| Retained Earnings | $-1.28B | $-1.19B | $-1.10B | $-1.04B | $-978M | $-918M | $-873M | $-832M | $-802M | $-771M | $-742M | $-728M | $-715M | $-693M | $-671M | $-628M | |
| AOCI | $793.0K | $802.0K | $961.0K | $919.0K | $832.0K | $923.0K | $1M | $1M | $792.0K | $836.0K | $864.0K | $841.0K | $842.0K | $843.0K | $786.0K | $653.0K | |
| Stockholders' Equity | $166M | $230M | $306M | $200M | $246M | $298M | $337M | $219M | $228M | $250M | $266M | $59M | $57M | $78M | $96M | $136M | |
| Liabilities + Equity | $228M | $288M | $364M | $252M | $301M | $363M | $418M | $301M | $324M | $329M | $355M | $160M | $176M | $155M | $180M | $220M | |
| Shares Outstanding | 84,981,843 | 83,453,001 | 82,826,416 | 69,569,813 | 68,889,649 | 68,811,357 | 68,266,005 | 53,524,364 | 52,160,305 | 49,885,701 | 49,043,074 | 35,309,432 | 34,306,118 | 34,301,926 | 34,082,934 | 34,072,155 |
Nakit Akışı 14
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $690.0K | $636.0K | $698.0K | $576.0K | $538.0K | $497.0K | $467.0K | $408.0K | $362.0K | $303.0K | $112.0K | · | · | · | · | · | |
| Stock-based Comp | $10M | $12M | $7M | $6M | $7M | $8M | $8M | $7M | $9M | $13M | $4M | $4M | $2M | $3M | $3M | $3M | |
| Deferred Tax | · | · | $369.0K | $0 | · | · | $90.0K | $0 | · | · | · | · | · | · | · | · | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $205.0K | $615.0K | |
| Other Non-cash | · | $-8M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-62M | $-81M | $-65M | $-59M | $-63M | $-53M | $-36M | $-39M | $-20M | $-31M | $-23M | $-15M | $57M | $-17M | $-13M | $-13M | |
| CapEx | $1M | $997.0K | $986.0K | $798.0K | $1M | $276.0K | $384.0K | $2M | $900.0K | $1M | $883.0K | $2M | $396.0K | $484.0K | $585.0K | $1M | |
| Investing Cash Flow | $75M | $59M | $-75M | $55M | $48M | $40M | $-96M | $16M | $-160M | $21M | $-47M | $-2M | $13M | $32M | $33M | $6M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Stock Issued | · | · | $167M | $7M | · | · | $152M | · | · | · | $216M | · | · | · | $0 | · | |
| Financing Cash Flow | $20M | $-3M | $167M | $7M | $238.0K | $-951.0K | $152M | $12M | $329.0K | $115.0K | $218M | $10M | $-37M | $-5M | $-58.0K | $92.0K | |
| Net Change in Cash | $33M | $-24M | $27M | $3M | $-14M | $-15M | $20M | $-11M | $-180M | $-10M | $148M | $-7M | $34M | $10M | $20M | $-7M | |
| Free Cash Flow | · | $-82M | · | · | · | $-53M | · | · | · | $-32M | · | · | · | $-17M | · | · |
Kârlılık 7
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -19207.1% | -12532.5% | · | -6420.8% | -1166.8% | -199.7% | · | -311.2% | -364.5% | -285.2% | · | -94.7% | -250.0% | -280.5% | · | -183.8% | |
| Net Margin | -18633.1% | -12188.5% | · | -6183.4% | -1114.3% | -184.8% | · | -279.0% | -325.3% | -250.6% | · | -83.0% | -251.7% | -275.5% | · | -184.0% | |
| Pretax Margin | -18633.1% | · | · | -6183.4% | -1112.6% | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -19207.1% | -12441.1% | · | -6420.8% | -1166.8% | -199.7% | · | -311.2% | -364.5% | -285.2% | · | -94.7% | -250.0% | -280.5% | · | -183.8% | |
| ROA | -35.7% | -26.1% | · | -21.6% | -19.0% | -13.1% | · | -12.7% | -12.3% | -12.1% | · | -6.6% | -11.2% | -10.6% | · | -9.5% | |
| ROE | -45.8% | -32.1% | · | -28.5% | -25.1% | -16.5% | · | -21.2% | -21.6% | -17.8% | · | -12.9% | -22.0% | -17.3% | · | -16.1% | |
| ROIC | -58.5% | · | · | -31.0% | -25.3% | · | · | · | · | · | · | · | · | · | · | · |
Likidite ve Solventlik 5
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.5 | 6.7 | · | 7.2 | 8.0 | 7.8 | · | 5.5 | 4.7 | 5.1 | · | 2.4 | 2.4 | 5.4 | · | 5.6 | |
| Quick Ratio | 4.3 | 5.9 | · | 6.8 | 7.7 | 7.6 | · | 5.2 | 4.5 | 4.8 | · | 2.1 | 2.1 | 4.5 | · | 4.6 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.4 | · | 0.3 | |
| LT Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.4 | · | 0.2 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | · | -52.3 | -26.5 | · | -27.8 |
Verimlilik 2
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.1 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.0 | 0.0 | · | 0.1 | |
| Inventory Turnover | · | · | · | · | · | · | · | 0.2 | 0.4 | 0.2 | · | · | · | · | · | · |
Değerleme (TTM) 14
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $8M | $31M | · | $41M | $50M | $56M | · | $47M | $45M | $44M | · | $42M | $38M | $39M | · | $40M | |
| Net Income TTM | $-298M | $-249M | · | $-194M | $-165M | $-135M | · | $-102M | $-96M | $-86M | · | $-75M | $-82M | $-80M | · | $-75M | |
| Market Cap | $1.22B | $1.08B | · | $991M | $648M | $373M | · | $428M | $454M | $1.03B | · | $282M | $298M | $101M | · | $270M | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | $146M | $156M | $13M | · | $152M | |
| P/E | -3.8 | -3.9 | · | -4.9 | -3.6 | -2.3 | · | -4.0 | -4.2 | -10.1 | · | -4.0 | -4.0 | -1.4 | · | -3.7 | |
| P/S | 162.0 | 34.2 | · | 24.0 | 13.0 | 6.6 | · | 9.1 | 10.0 | 23.6 | · | 6.7 | 7.8 | 2.6 | · | 6.7 | |
| P/B | 7.3 | 4.7 | · | 4.9 | 2.6 | 1.2 | · | 2.0 | 2.0 | 4.1 | · | 4.8 | 5.2 | 1.3 | · | 2.0 | |
| P / Tangible Book | 7.3 | 4.7 | · | 4.9 | 2.6 | 1.2 | · | 2.0 | 2.0 | 4.1 | · | 4.8 | 5.2 | 1.3 | · | 2.3 | |
| P / Cash Flow | · | -13.4 | · | · | · | -7.0 | · | · | · | -33.1 | · | · | · | -6.0 | · | · | |
| P / FCF | · | -13.2 | · | · | · | -7.0 | · | · | · | -31.9 | · | · | · | -5.8 | · | · | |
| EV / EBITDA | · | · | · | · | · | · | · | · | · | · | · | -10.1 | -6.9 | -0.6 | · | -8.3 | |
| EV / FCF | · | · | · | · | · | · | · | · | · | · | · | · | · | -0.8 | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | · | · | 3.5 | 4.1 | 0.3 | · | 3.8 | |
| Earnings Yield | -26.4% | -25.9% | · | -20.3% | -27.8% | -42.8% | · | -25.0% | -23.8% | -9.9% | · | -24.9% | -25.1% | -72.5% | · | -27.2% |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Gelir | $31M | $43M | $46M | $41M | $37M |
| Faaliyet Kâr Marjı % | -776.0% | -337.1% | -163.1% | -240.6% | -149.6% |
| Net Gelir | $-232M | $-131M | $-71M | $-102M | $-58M |
| Seyreltilmiş Hisse Başı Kâr | $-3.17 | $-2.32 | $-1.82 | $-2.74 | $-2.03 |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | — | — | 0.0 | 0.4 | 0.2 |
| Cari Oran | 8.9 | 7.8 | 5.5 | 5.0 | 10.0 |
| Cari Oran | 8.3 | 7.6 | 5.2 | 4.2 | 8.9 |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-243M | $-130M | $-2M | $-67M | $-50M |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kurumsal Sahipler (13F) 217 dosya · $1.2B toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 37 (-18 önceki Ç'ye göre) | 20 (-3 önceki Ç'ye göre) | 63 (-9 önceki Ç'ye göre) | 56 (+18 önceki Ç'ye göre) | +8.5M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| MONTANOVA CAPITAL, LLC | $118.638.163 | 8.296.375 | 10,19% | Hisse senetleri |
| Cormorant Asset Management, LP | $100.100.000 | 7.000.000 | 8,60% | Hisse senetleri |
| VANGUARD GROUP INC | $78.353.343 | 4.288.634 | 6,73% | Hisse senetleri |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $69.037.426 | 4.827.792 | 5,93% | Hisse senetleri |
| Commodore Capital LP | $65.780.000 | 4.600.000 | 5,65% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $51.912.604 | 3.630.252 | 4,46% | Hisse senetleri |
| JANUS HENDERSON GROUP PLC | $45.962.750 | 3.565.768 | 3,95% | Hisse senetleri |
| Paradigm Biocapital Advisors LP | $41.332.677 | 2.890.397 | 3,55% | Hisse senetleri |
| STATE STREET CORP | $33.712.894 | 2.357.545 | 2,90% | Hisse senetleri |
| Aberdeen Group plc | $28.725.869 | 2.008.802 | 2,47% | Hisse senetleri |
| PERCEPTIVE ADVISORS LLC | $28.600.000 | 2.000.000 | 2,46% | Satım opsiyonu |
| Balyasny Asset Management L.P. | $25.916.719 | 1.812.358 | 2,23% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $25.269.659 | 1.766.745 | 2,17% | Hisse senetleri |
| CITADEL ADVISORS LLC | $25.214.389 | 1.763.244 | 2,17% | Hisse senetleri |
| Parkman Healthcare Partners LLC | $18.420.731 | 1.288.163 | 1,58% | Hisse senetleri |
| EVENTIDE ASSET MANAGEMENT, LLC | $17.811.837 | 1.245.583 | 1,53% | Hisse senetleri |
| TWO SIGMA INVESTMENTS, LP | $16.890.345 | 1.181.143 | 1,45% | Hisse senetleri |
| Essex Woodlands Management, Inc. | $15.513.455 | 1.084.857 | 1,33% | Hisse senetleri |
| ORBIMED ADVISORS LLC | $15.288.802 | 1.069.147 | 1,31% | Hisse senetleri |
| 5AM Venture Management, LLC | $15.015.000 | 1.050.000 | 1,29% | Hisse senetleri |
| Rosalind Advisors, Inc. | $14.131.689 | 988.230 | 1,21% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $13.885.500 | 971.014 | 1,19% | Hisse senetleri |
| HSBC HOLDINGS PLC | $11.918.407 | 833.455 | 1,02% | Hisse senetleri |
| Candriam S.C.A. | $11.254.258 | 787.769 | 0,97% | Hisse senetleri |
| AMERIPRISE FINANCIAL INC | $11.087.640 | 775.357 | 0,95% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $11.062.981 | 773.635 | 0,95% | Hisse senetleri |
| Artia Global Partners LP | $10.969.501 | 767.098 | 0,94% | Hisse senetleri |
| Blue Owl Capital Holdings LP | $10.905.094 | 762.594 | 0,94% | Hisse senetleri |
| Patient Square Capital LP | $10.296.000 | 720.000 | 0,88% | Hisse senetleri |
| Principia Wealth Advisory, LLC | $9.696.346 | 530.725 | 0,83% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $9.260.866 | 647.613 | 0,80% | Hisse senetleri |
| Sio Capital Management, LLC | $8.910.759 | 623.130 | 0,77% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $7.996.789 | 559.216 | 0,69% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $7.899.320 | 552.400 | 0,68% | Alım opsiyonu |
| Alyeska Investment Group, L.P. | $7.284.463 | 509.403 | 0,63% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $7.151.330 | 500.093 | 0,61% | Hisse senetleri |
| Simplify Asset Management Inc. | $5.720.629 | 400.044 | 0,49% | Hisse senetleri |
| Ikarian Capital, LLC | $5.296.720 | 370.400 | 0,46% | Alım opsiyonu |
| Ikarian Capital, LLC | $5.296.720 | 370.400 | 0,46% | Satım opsiyonu |
| Ghisallo Capital Management LLC | $5.005.000 | 350.000 | 0,43% | Hisse senetleri |
| STEMPOINT CAPITAL LP | $4.840.135 | 338.471 | 0,42% | Hisse senetleri |
| E Fund Management Co., Ltd. | $4.730.068 | 330.774 | 0,41% | Hisse senetleri |
| Jump Financial, LLC | $4.586.825 | 320.757 | 0,39% | Hisse senetleri |
| Bleichroeder LP | $4.526.165 | 316.515 | 0,39% | Hisse senetleri |
| Woodline Partners LP | $4.296.621 | 300.463 | 0,37% | Hisse senetleri |
| Eversept Partners, LP | $4.257.610 | 297.735 | 0,37% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $4.086.797 | 285.790 | 0,35% | Hisse senetleri |
| Rock Springs Capital Management LP | $3.839.822 | 268.519 | 0,33% | Hisse senetleri |
| CITIGROUP INC | $3.750.032 | 262.240 | 0,32% | Hisse senetleri |
| MYDA Advisors LLC | $3.575.000 | 250.000 | 0,31% | Hisse senetleri |
| AXA Investment Managers S.A. | $3.480.640 | 244.427 | 0,30% | Hisse senetleri |
| UBS Group AG | $3.373.442 | 235.905 | 0,29% | Hisse senetleri |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $3.342.639 | 233.751 | 0,29% | Hisse senetleri |
| Schonfeld Strategic Advisors LLC | $3.285.853 | 229.780 | 0,28% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3.038.750 | 212.500 | 0,26% | Satım opsiyonu |
| Propel Bio Management, LLC | $2.741.954 | 191.745 | 0,24% | Hisse senetleri |
| Qube Research & Technologies Ltd | $2.704.159 | 189.102 | 0,23% | Hisse senetleri |
| Walleye Capital LLC | $2.691.560 | 188.221 | 0,23% | Hisse senetleri |
| Susquehanna Portfolio Strategies, LLC | $2.685.554 | 187.801 | 0,23% | Hisse senetleri |
| BlackRock, Inc. | $2.649.890 | 185.307 | 0,23% | Hisse senetleri |
| CITADEL ADVISORS LLC | $2.559.700 | 179.000 | 0,22% | Satım opsiyonu |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $2.389.303 | 169.334 | 0,21% | Hisse senetleri |
| HighVista Strategies LLC | $2.226.567 | 155.704 | 0,19% | Hisse senetleri |
| Granahan Investment Management, LLC | $2.136.234 | 149.387 | 0,18% | Hisse senetleri |
| Swiss National Bank | $2.034.890 | 142.300 | 0,17% | Hisse senetleri |
| STATE OF WISCONSIN INVESTMENT BOARD | $1.998.711 | 139.770 | 0,17% | Hisse senetleri |
| PANAGORA ASSET MANAGEMENT INC | $1.890.660 | 132.214 | 0,16% | Hisse senetleri |
| Corient Private Wealth LP | $1.827.526 | 127.799 | 0,16% | Hisse senetleri |
| ESSEX INVESTMENT MANAGEMENT CO LLC | $1.740.081 | 121.684 | 0,15% | Hisse senetleri |
| BOOTHBAY FUND MANAGEMENT, LLC | $1.548.690 | 108.300 | 0,13% | Alım opsiyonu |
| BOOTHBAY FUND MANAGEMENT, LLC | $1.548.690 | 108.300 | 0,13% | Satım opsiyonu |
| DIADEMA PARTNERS LP | $1.520.090 | 106.300 | 0,13% | Alım opsiyonu |
| SILVERBACK ASSET MANAGEMENT LLC | $1.430.000 | 100.000 | 0,12% | Alım opsiyonu |
| Squarepoint Ops LLC | $1.401.429 | 98.002 | 0,12% | Hisse senetleri |
| RHUMBLINE ADVISERS | $1.393.341 | 97.437 | 0,12% | Hisse senetleri |
| CITADEL ADVISORS LLC | $1.357.070 | 94.900 | 0,12% | Alım opsiyonu |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $1.354.752 | 105.101 | 0,12% | Hisse senetleri |
| ALGERT GLOBAL LLC | $1.129.557 | 78.990 | 0,10% | Hisse senetleri |
| Waverly Advisors, LLC | $1.114.170 | 77.914 | 0,10% | Hisse senetleri |
| Cinctive Capital Management LP | $1.037.923 | 72.582 | 0,09% | Hisse senetleri |
| Caption Management, LLC | $1.036.750 | 72.500 | 0,09% | Alım opsiyonu |
| WELLINGTON MANAGEMENT GROUP LLP | $1.035.134 | 72.387 | 0,09% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $1.002.430 | 70.100 | 0,09% | Alım opsiyonu |
| DEUTSCHE BANK AG\ | $989.860 | 69.221 | 0,09% | Hisse senetleri |
| Bank of New York Mellon Corp | $981.824 | 68.659 | 0,08% | Hisse senetleri |
| WOODSTOCK CORP | $979.049 | 68.465 | 0,08% | Hisse senetleri |
| ALLIANCEBERNSTEIN L.P. | $971.081 | 75.336 | 0,08% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $930.186 | 65.048 | 0,08% | Hisse senetleri |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $865.708 | 60.539 | 0,07% | Hisse senetleri |
| FOX RUN MANAGEMENT, L.L.C. | $836.950 | 58.528 | 0,07% | Hisse senetleri |
| Y-Intercept (Hong Kong) Ltd | $732.017 | 51.190 | 0,06% | Hisse senetleri |
| SILVERBACK ASSET MANAGEMENT LLC | $715.000 | 50.000 | 0,06% | Hisse senetleri |
| JANE STREET GROUP, LLC | $715.000 | 50.000 | 0,06% | Alım opsiyonu |
| Erste Asset Management GmbH | $705.500 | 50.000 | 0,06% | Hisse senetleri |
| VANGUARD ASSET MANAGEMENT, Ltd | $702.545 | 49.129 | 0,06% | Hisse senetleri |
| Point72 Asset Management, L.P. | $694.608 | 48.574 | 0,06% | Hisse senetleri |
| SBI Okasan Asset Management Co.Ltd. | $644.827 | 45.700 | 0,06% | Hisse senetleri |
| MetLife Investment Management, LLC | $621.607 | 43.469 | 0,05% | Hisse senetleri |
| JANE STREET GROUP, LLC | $597.954 | 41.815 | 0,05% | Hisse senetleri |
| SCOTIA CAPITAL INC. | $597.039 | 41.751 | 0,05% | Hisse senetleri |
Şirket yöneticileri 25 içeriden öğrenenler · 12 yöneticiler · 16 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Jay S. Duker | President and CEO | 10 Temmuz 2026 M | 9.594 | 0 | 0 | $0 |
| Nancy Lurker | President & CEO | 12 Ekim 2018 A | 211.700 | 0 | 0 | $0 |
| Paul Ashton | President & CEO | 18 Mart 2016 M | 450.741 | 0 | 0 | $0 |
| David Price | Chief Financial Officer | 01 Ağustos 2018 A | — | 0 | 0 | $0 |
| Michael Soja | VP Finance, CFO & Treasurer | 10 Eylül 2008 A | — | 0 | 0 | $0 |
| Ramiro Ribeiro | Chief Medical Officer | 30 Haziran 2026 M | 0 | 0 | 2 | $-73.174 |
| Leonard S Ross | Vice President of Finance and Chief Accounting Officer | 22 Aralık 2018 M | 76.187 | 0 | 0 | $0 |
| Dario A. Paggiarino | Chief Medical Officer | 12 Ekim 2018 F | 29.600 | 0 | 0 | $0 |
| Leonard M Blum | Executive VP and General Manager, US | 14 Mayıs 2018 A | — | 0 | 0 | $0 |
| Debora Jorn | EVP, Corp. & Comm'l Dev. | 27 Haziran 2017 A | — | 0 | 0 | $0 |
| Lori Freedman | VP Corporate Affairs, General Counsel and Secretary | 21 Temmuz 2016 A | 96.423 | 0 | 0 | $0 |
| Aaron Finlay | Secretary | 18 Ekim 2007 A | — | 0 | 0 | $0 |
| Karen L. Zaderej | Yönetim kurulu üyesi | 18 Ağustos 2026 P | 49.100 | 1 | 0 | $52.258 |
| Wendy F Dicicco | Yönetim kurulu üyesi | 02 Ocak 2026 A | — | 0 | 0 | $0 |
| ANDO GORAN | Yönetim kurulu üyesi | 02 Ocak 2026 A | — | 0 | 0 | $0 |
| Fred Hassan | Yönetim kurulu üyesi | 02 Ocak 2026 A | — | 0 | 0 | $0 |
| Michael W Rogers | Yönetim kurulu üyesi | 15 Kasım 2018 M | 112.500 | 0 | 0 | $0 |
| John B. Landis | Yönetim kurulu üyesi | 25 Ekim 2018 A | — | 0 | 0 | $0 |
| David J Mazzo | Yönetim kurulu üyesi | 06 Eylül 2018 A | 138.000 | 0 | 0 | $0 |
| Douglas Evan Godshall | Yönetim kurulu üyesi | 27 Haziran 2018 M | 12.500 | 0 | 0 | $0 |
| James J Barry | Yönetim kurulu üyesi | 07 Mayıs 2018 M | 12.500 | 0 | 0 | $0 |
| Kristine Peterson | Yönetim kurulu üyesi | 15 Aralık 2017 A | — | 0 | 0 | $0 |
| SAVAS PETER G | Yönetim kurulu üyesi | 03 Aralık 2015 A | — | 0 | 0 | $0 |
| Paul Hopper | Yönetim kurulu üyesi | 18 Aralık 2013 A | 10.000 | 0 | 0 | $0 |
| Katherine Woodthorpe | Yönetim kurulu üyesi | 27 Kasım 2007 A | — | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
Aktivistler ve %5+ sahipler 5 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| EW Healthcare Partners L.P., EW Healthcare Partners-A L.P., Essex Woodlands Fund IX-GP, L.P., Essex Woodlands IX, LLC, Martin P. Sutter, R. Scott Barry, Ronald Eastman, Petri Vainio, Steve Wiggins ×4 başvurular | 08 Aralık 2023 | — | İlk başvuru | — | SEC |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 30 Ağustos 2023 | — | İlk başvuru | — | SEC |
| Ocumension Therapeutics | 22 Ocak 2021 | — | İlk başvuru | — | SEC |
| IRS Identification Nos. of above persons (entities only) Pfizer Inc. ×2 başvurular | 26 Mayıs 2017 | — | İlk başvuru | — | SEC |
| Pfizer Inc. | 17 Temmuz 2007 | — | İlk başvuru | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF sahipliği 42 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| PILL · Direxion Shares ETF Trust | 1,18% | 11.564 NS | 30 Nisan 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,61% | 17.260 NS | 30 Nisan 2026 | N-PORT |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,51% | 8.244 SH | 08 Ağustos 2026 | Günlük |
| IWC · iShares Trust | 0,23% | 262.360 SH | 08 Ağustos 2026 | Günlük |
| IHE · iShares Trust | 0,22% | 281.199 SH | 08 Ağustos 2026 | Günlük |
| FSCC · Federated Hermes ETF Trust | 0,12% | 25.180 NS | 31 Mayıs 2026 | N-PORT |
| NUSC · Nushares ETF Trust | 0,08% | 78.250 NS | 30 Nisan 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,08% | 4.561 SH | 08 Ağustos 2026 | Günlük |
| VFMO · VANGUARD WELLINGTON FUND | 0,06% | 86.797 SH | 08 Ağustos 2026 | Günlük |
| BIB · ProShares Trust | 0,06% | 3.062 NS | 31 Mayıs 2026 | N-PORT |
| IWO · iShares Trust | 0,05% | 592.383 SH | 08 Ağustos 2026 | Günlük |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,05% | 69.310 SH | 08 Ağustos 2026 | Günlük |
| GSSC · Goldman Sachs ETF Trust | 0,04% | 25.575 NS | 31 Mayıs 2026 | N-PORT |
| IWM · iShares Trust | 0,03% | 1.980.136 SH | 08 Ağustos 2026 | Günlük |
| RSSL · Global X Funds | 0,03% | 33.518 NS | 30 Nisan 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,03% | 445.218 SH | 08 Ağustos 2026 | Günlük |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,03% | 61.360 SH | 08 Ağustos 2026 | Günlük |
| ISCV · iShares Trust | 0,03% | 15.627 SH | 08 Ağustos 2026 | Günlük |
| ITWO · ProShares Trust | 0,03% | 3.648 NS | 31 Mayıs 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,02% | 378.469 NS | 31 Mayıs 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 34.174 NS | 30 Nisan 2026 | N-PORT |
| UWM · ProShares Trust | 0,02% | 2.853 NS | 31 Mayıs 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,01% | 152.391 NS | 30 Nisan 2026 | N-PORT |
| ISCB · iShares Trust | 0,01% | 3.155 SH | 08 Ağustos 2026 | Günlük |
| URTY · ProShares Trust | 0,01% | 2.885 NS | 31 Mayıs 2026 | N-PORT |
| IWN · iShares Trust | 0,01% | 120.933 SH | 08 Ağustos 2026 | Günlük |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 901.417 SH | 08 Ağustos 2026 | Günlük |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 11.210 SH | 08 Ağustos 2026 | Günlük |
| VHT · VANGUARD WORLD FUND | 0,01% | 213.549 SH | 08 Ağustos 2026 | Günlük |
| WSML · iShares Trust | 0,01% | 4.526 SH | 08 Ağustos 2026 | Günlük |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 2.895 NS | 31 Mayıs 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 72 NS | 31 Mayıs 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,00% | 28.026 NS | 31 Mayıs 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 3.564 NS | 30 Nisan 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 111.667 SH | 08 Ağustos 2026 | Günlük |
| IWV · iShares Trust | 0,00% | 21.976 SH | 08 Ağustos 2026 | Günlük |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 46.188 NS | 31 Mayıs 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 10.667 NS | 30 Nisan 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 41.879 NS | 30 Nisan 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 13.282 NS | 30 Nisan 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2.643.860 SH | 08 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 6.035 SH | 08 Ağustos 2026 | Günlük |